Streptomycin is useful in the treatment of which of the following conditions?
Grey baby syndrome is caused by which of the following drugs?
Which one of the following statements about doxycycline is false?
Which of the following represents an orally available fixed Beta-Lactamase Inhibitor and Antibiotic Combination?
Which monoclonal antibody neutralizes anthrax toxin?
Which among the following anti-HIV drugs is an inhibitor of viral fusion?
Tecovirimat is a recently approved anti-viral drug. Against which virus is it used?
All of the following drugs inhibit cell wall synthesis except?
What is the drug of choice for treating Echinococcus granulosus infection?
What is the drug of choice for treating P. vivax malaria in a pregnant woman?
Explanation: **Explanation:** Streptomycin, an aminoglycoside, is considered a second-line or alternative treatment for **Granuloma venereum** (also known as Donovanosis), caused by *Klebsiella granulomatis*. While macrolides (Azithromycin) are currently the first-line treatment, streptomycin remains a classic pharmacological association for this condition in competitive exams. **Analysis of Options:** * **Granuloma venereum (Correct):** Characterized by painless, beefy-red ulcerative lesions. Diagnosis is confirmed by identifying **Donovan bodies** (safety-pin appearance) in tissue smears. Streptomycin (1g IM twice daily) is an effective alternative therapy. * **Lymphogranuloma venereum (LGV):** Caused by *Chlamydia trachomatis* (serotypes L1-L3). The treatment of choice is **Doxycycline** or Erythromycin. Aminoglycosides like streptomycin are ineffective against intracellular *Chlamydia*. * **Syphilis:** Caused by *Treponema pallidum*. The drug of choice is **Benzathine Penicillin G**. Streptomycin has no role in treating spirochetal infections. * **Chancroid:** Caused by *Haemophilus ducreyi* (painful ulcers). The preferred treatments are **Azithromycin**, Ceftriaxone, or Ciprofloxacin. **High-Yield Clinical Pearls for NEET-PG:** * **Streptomycin Uses:** Remember the mnemonic **"T-P-G-H"**: **T**uberculosis (1st line), **P**lague (*Yersinia pestis* - Drug of Choice), **G**ranuloma venereum, and **H**uman Tularemia. * **Adverse Effects:** It is the most vestibulotoxic aminoglycoside (causing vertigo and nystagmus) and is contraindicated in pregnancy due to the risk of fetal ototoxicity. * **Mechanism:** It inhibits bacterial protein synthesis by binding to the **30S ribosomal subunit**, causing misreading of mRNA.
Explanation: Chloramphenicol is the correct answer. Grey baby syndrome is a serious, potentially fatal adverse reaction that occurs in neonates (especially premature infants) treated with high doses of chloramphenicol [2]. **The Underlying Mechanism:** The syndrome occurs due to two physiological deficiencies in neonates: 1. **Glucuronosyltransferase Deficiency:** Neonates lack sufficient levels of this hepatic enzyme, which is required to conjugate chloramphenicol into its inactive form [2]. 2. **Inadequate Renal Excretion:** Immature kidneys cannot effectively excrete the unconjugated drug [2]. This leads to the systemic accumulation of the drug, causing mitochondrial toxicity. Clinical features include abdominal distension, vomiting, progressive pallor, cyanosis (giving the "grey" appearance), and circulatory collapse. **Analysis of Incorrect Options:** * **A. Amikacin:** An aminoglycoside primarily associated with **nephrotoxicity** and **ototoxicity** (vestibulocochlear nerve damage). * **B. Tetracycline:** Known for causing **permanent discoloration of teeth** and inhibition of bone growth in children due to its chelating property with calcium [3]. * **C. Vancomycin:** Classically associated with **"Red Man Syndrome"** (an infusion-related reaction caused by histamine release) and ototoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Bone Marrow Toxicity:** Chloramphenicol also causes dose-dependent anemia and idiosyncratic **Aplastic Anemia** (the latter is not dose-related and can be fatal). * **Mechanism of Action:** It inhibits protein synthesis by binding to the **50S ribosomal subunit** (inhibits peptidyl transferase). * **Drug of Choice:** While its use is limited due to toxicity, it remains a drug of choice for **Enteric fever** (in specific resistant cases) [1] and bacterial meningitis in patients with severe penicillin allergy [2].
Explanation: **Explanation:** The correct answer is **C**. While doxycycline is a versatile tetracycline, **tetracycline (HCl)** is specifically preferred over doxycycline in the standard quadruple therapy for *H. pylori* eradication. Clinical studies show that tetracycline achieves better mucosal concentrations and efficacy against *H. pylori* compared to doxycycline. **Analysis of Options:** * **A. It is bacteriostatic:** Like all tetracyclines, doxycycline inhibits protein synthesis by binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA. This action is reversible and inhibits growth rather than killing the bacteria. * **B. It is excreted mainly in the feces:** Doxycycline is unique among tetracyclines because it is primarily excreted into the gut via bile and eliminated in feces. This makes it the **tetracycline of choice in patients with renal failure**, as it does not accumulate in the blood. * **D. It is used in Lyme's disease:** Doxycycline is the **first-line drug of choice** for early-stage Lyme disease (*Borrelia burgdorferi*), as well as for Rickettsial infections and Chlamydia. **High-Yield Clinical Pearls for NEET-PG:** * **Phototoxicity:** Doxycycline is the most common tetracycline to cause skin photosensitivity. * **Contraindications:** Avoid in pregnancy and children <8 years due to permanent tooth discoloration and bone growth retardation. * **Absorption:** Unlike older tetracyclines, doxycycline absorption is **not** significantly affected by food or milk. * **Prophylaxis:** It is used for the prophylaxis of Malaria (in mefloquine-resistant areas) and Leptospirosis.
Explanation: ### Explanation The correct answer is **Amoxicillin-Clavulanic acid**. **1. Why Amoxicillin-Clavulanic acid is correct:** The primary factor determining the route of administration for beta-lactam combinations is the **acid stability** and **bioavailability** of both components. Amoxicillin is acid-stable and highly absorbed from the gastrointestinal tract. Clavulanic acid also possesses excellent oral bioavailability. Together, they form a fixed-dose combination (e.g., Augmentin) that is effective orally for community-acquired infections like sinusitis, otitis media, and animal bites. **2. Why the other options are incorrect:** * **Ampicillin-Sulbactam:** While ampicillin can be given orally, its absorption is inconsistent and decreased by food. Sulbactam has very poor oral bioavailability. Therefore, this combination is administered **parenterally** (IV/IM). (Note: *Sultamicillin* is an oral prodrug of this combination, but the standard combination listed is parenteral). * **Piperacillin-Tazobactam:** Piperacillin is a broad-spectrum antipseudonal penicillin that is degraded by gastric acid. It must be administered **intravenously**. It is a mainstay for hospital-acquired infections. * **Ticarcillin-Clavulanic Acid:** Ticarcillin is not acid-stable and is only available for **parenteral** use. **3. High-Yield NEET-PG Pearls:** * **Suicide Inhibitors:** Clavulanic acid, Sulbactam, and Tazobactam are "suicide inhibitors" because they permanently bind to and inactivate beta-lactamases. * **Newer Agents:** Avibactam and Relebactam are non-beta-lactam beta-lactamase inhibitors used with carbapenems or cephalosporins for MDR organisms. * **Sultamicillin:** This is a double ester of Ampicillin and Sulbactam, designed specifically to provide an **oral** formulation of that combination. * **Side Effect:** Amoxicillin-Clavulanate is a common cause of drug-induced cholestatic jaundice.
Explanation: **Explanation:** **Raxibacumab** is a recombinant human IgG1 monoclonal antibody specifically designed to treat inhalational anthrax caused by *Bacillus anthracis*. Its mechanism of action involves binding to the **Protective Antigen (PA)** component of the anthrax toxin. By neutralizing PA, it prevents the toxin from binding to host cell receptors, thereby inhibiting the entry of Lethal Factor (LF) and Edema Factor (EF) into the cells. This prevents the systemic toxemia that often leads to death even after the bacteria have been cleared by antibiotics. (Note: **Obiltoxaximab** is another mAb with a similar mechanism). **Analysis of Incorrect Options:** * **Cetuximab:** A chimeric monoclonal antibody that targets the **Epidermal Growth Factor Receptor (EGFR)**. It is primarily used in the treatment of metastatic colorectal cancer and head and neck squamous cell carcinoma. * **Panitumumab:** A fully human monoclonal antibody that also targets **EGFR**. It is used for the treatment of EGFR-expressing metastatic colorectal cancer. * **Alemtuzumab:** A monoclonal antibody directed against **CD52**, a protein found on the surface of mature lymphocytes. It is used in the treatment of B-cell chronic lymphocytic leukemia (CLL) and Multiple Sclerosis (MS). **High-Yield Clinical Pearls for NEET-PG:** * **Anthrax Toxin Components:** It is a tripartite toxin consisting of Protective Antigen (PA), Lethal Factor (LF), and Edema Factor (EF). * **Drug of Choice:** While Raxibacumab manages the toxin, the antibiotic drug of choice for post-exposure prophylaxis and treatment of Anthrax is **Ciprofloxacin** (or Doxycycline). * **Bezlotoxumab:** Do not confuse Raxibacumab with Bezlotoxumab, which is a monoclonal antibody used to prevent the recurrence of *Clostridioides difficile* infection by neutralizing Toxin B.
Explanation: **Explanation:** **1. Why Enfuvirtide is correct:** Enfuvirtide is a synthetic peptide that acts as a **Fusion Inhibitor**. It specifically binds to the **gp41** subunit of the viral envelope glycoprotein. By binding to gp41, it prevents the conformational changes required for the fusion of the HIV-1 envelope with the host cell (CD4 T-cell) membrane. Since it prevents the virus from entering the cell, it is classified as an entry inhibitor. It is administered subcutaneously. **2. Analysis of Incorrect Options:** * **B. Nelfinavir:** This is a **Protease Inhibitor (PI)**. It works by inhibiting the viral protease enzyme, which is responsible for cleaving precursor polypeptides into functional proteins, thereby preventing the maturation of the virus. * **C. Efavirenz:** This is a **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)**. It binds directly to the reverse transcriptase enzyme to inhibit the synthesis of viral DNA from RNA. * **D. Etanercept:** This is **not an anti-HIV drug**. It is a TNF-alpha inhibitor (a fusion protein of the TNF receptor and IgG1 Fc) used in the treatment of autoimmune conditions like Rheumatoid Arthritis and Psoriasis. **3. NEET-PG High-Yield Pearls:** * **Maraviroc:** Another entry inhibitor, but it acts by binding to the **CCR5 receptor** on the host cell (not gp41). * **gp120 vs gp41:** Remember that **gp120** is for *attachment* (to CD4), while **gp41** is for *fusion/penetration*. * **Side Effect of Enfuvirtide:** Injection site reactions (nodules, erythema) occur in nearly 100% of patients. * **Salvage Therapy:** Enfuvirtide is typically reserved for "treatment-experienced" patients with multidrug-resistant HIV.
Explanation: **Explanation:** **Tecovirimat** is a novel, first-in-class antiviral medication specifically developed and approved for the treatment of **Smallpox** (caused by the *Variola virus*). It was approved by the FDA under the "Animal Rule" to bolster biodefense preparedness. **Mechanism of Action:** Tecovirimat works by inhibiting the **VP37 envelope wrapping protein**, which is highly conserved across orthopoxviruses. By blocking this protein, the drug prevents the formation of egress-competent enveloped virions, thereby stopping the virus from spreading from cell to cell within the host. **Analysis of Incorrect Options:** * **B. Chickenpox:** Caused by the *Varicella-Zoster Virus* (a herpesvirus). The standard treatment involves DNA polymerase inhibitors like **Acyclovir** or Valacyclovir. Tecovirimat is ineffective against herpesviruses. * **C. Dengue:** A flavivirus for which there is currently no specific antiviral therapy. Management is primarily supportive (fluid resuscitation). * **D. Influenza:** Treated with neuraminidase inhibitors (e.g., **Oseltamivir**), endonuclease inhibitors (e.g., **Baloxavir marboxil**), or M2 ion channel blockers (e.g., Amantadine). **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** While approved for Smallpox, it also shows efficacy against other orthopoxviruses, including **Mpox (Monkeypox)** and Cowpox. * **Route:** Available in both oral and intravenous formulations. * **Resistance:** Resistance can develop via a single amino acid substitution in the VP37 protein; hence, it is often reserved for severe cases or biosecurity threats. * **Key Target:** Remember **VP37**—this is a frequent target for "mechanism of action" questions in recent exams.
Explanation: **Explanation:** The cell wall is a vital structure in bacteria, and drugs targeting its synthesis are generally bactericidal. To answer this question, one must distinguish between cell wall synthesis inhibitors and protein synthesis inhibitors. **Why Tetracycline is the correct answer:** **Tetracycline** is a bacteriostatic antibiotic that inhibits **protein synthesis**, not cell wall synthesis. It acts by reversibly binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. **Why the other options are incorrect:** * **Penicillin:** A Beta-lactam antibiotic that inhibits the final step of cell wall synthesis (transpeptidation) by binding to Penicillin-Binding Proteins (PBPs). * **Fosfomycin:** Inhibits the very first step of peptidoglycan synthesis by inhibiting the enzyme **MurA** (enolpyruvate transferase), preventing the formation of UDP-NAM. * **Vancomycin:** A glycopeptide that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing transglycosylation and transpeptidation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cell Wall Inhibitors:** "**P**enis **C**an't **B**eat **V**irgin **F**annies" (**P**enicillins, **C**ephalosporins, **B**acitracin, **V**ancomycin, **F**osfomycin/Cycloserine). * **Tetracycline Side Effects:** Fanconi syndrome (expired tetracyclines), tooth discoloration, and phototoxicity. * **Fosfomycin** is a first-line drug for uncomplicated UTIs (safe in pregnancy). * **Vancomycin** is the drug of choice for MRSA but can cause "Red Man Syndrome" due to histamine release if infused too rapidly.
Explanation: **Explanation:** **Echinococcus granulosus**, the causative agent of **Cystic Echinococcosis (Hydatid cyst disease)**, is primarily treated with benzimidazole derivatives. **Why Albendazole is the Correct Choice:** Albendazole is the **drug of choice** because it is a prodrug that is rapidly converted to its active metabolite, **albendazole sulfoxide**. Unlike other benzimidazoles, this metabolite achieves high concentrations in the liver, bile, and, most importantly, penetrates the **hydatid cyst wall** effectively. It works by inhibiting microtubule synthesis (binding to β-tubulin), leading to glucose depletion and death of the parasite. It is used as an adjunct to surgery (PAIR technique) or as primary therapy for inoperable cases. **Analysis of Incorrect Options:** * **B. Mebendazole:** While effective against many intestinal nematodes, it has **poor systemic absorption**. To reach therapeutic levels in a hydatid cyst, very high doses are required, leading to increased side effects compared to albendazole. * **C. Thiabendazole:** It is significantly more toxic than albendazole and is no longer the preferred agent for systemic helminthic infections. * **D. Praziquantel:** This is the drug of choice for **Schistosomiasis** and most trematodes/cestodes. In hydatid disease, it is sometimes used as an *adjunct* to albendazole to kill protoscoleces during surgery, but it is not the primary drug of choice. **High-Yield Clinical Pearls for NEET-PG:** * **Neurocysticercosis (NCC):** Albendazole is the drug of choice (Praziquantel is an alternative). * **Kala-azar:** Do not confuse with *Echinococcus*; Liposomal Amphotericin B is the DOC here. * **Monitoring:** Long-term albendazole therapy requires regular monitoring of **Liver Function Tests (LFTs)** and CBC due to risks of hepatotoxicity and bone marrow suppression.
Explanation: ### Explanation **Correct Option: B. Chloroquine** **Mechanism and Rationale:** Chloroquine remains the **drug of choice (DOC)** for sensitive *Plasmodium vivax* and *P. falciparum* malaria during all trimesters of pregnancy. It is highly effective against the erythrocytic stages of the parasite and has a well-established safety profile in pregnancy, showing no teratogenic effects. In *P. vivax* cases, Chloroquine clears the current infection; however, **Primaquine**, which is used for radical cure (to kill hypnozoites in the liver), is **strictly contraindicated** in pregnancy due to the risk of severe hemolysis in the fetus (who may be G6PD deficient). Therefore, pregnant women are maintained on Chloroquine prophylaxis until delivery. **Analysis of Incorrect Options:** * **A. Quinine:** While safe in pregnancy, it is generally reserved for Chloroquine-resistant malaria or severe/complicated malaria. It is not the first-line choice for uncomplicated *P. vivax*. * **C. Artemether:** Part of Artemisinin-based Combination Therapy (ACT). While ACTs are now used in the 2nd and 3rd trimesters for *P. falciparum*, Chloroquine is still preferred for *P. vivax* unless resistance is documented. * **D. Paracetamol:** This is an antipyretic used for symptomatic relief of fever; it has no antimalarial activity and cannot treat the underlying infection. **High-Yield Clinical Pearls for NEET-PG:** * **Radical Cure Delay:** In *P. vivax* pregnancy cases, give Chloroquine (treatment) followed by weekly Chloroquine (prophylaxis) until delivery. Administer Primaquine only **after** delivery and after checking the G6PD status of the mother and infant. * **Severe Malaria in Pregnancy:** Intravenous **Artesunate** is the DOC for severe malaria in all trimesters (benefits outweigh risks). * **Contraindicated in Pregnancy:** Primaquine, Pyrimethamine (relative), and Tetracyclines (Doxycycline).
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free